🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Andrea Aroldi

Azienda Ospedaliera San Gerardo

ORCID: 0000-0002-3428-5353

Also affiliated with Istituti di Ricovero e Cura a Carattere Scientifico, University of Milano-Bicocca

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer”.

Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer

npj Precision Oncology(2025)10.1038/s41698-025-01088-0

N/A

0.208DataRank · unranked

3 citations

Nicoletta Cordani, Alberto Maria Villa, Federica Malighetti, Matteo Villa, Luca Sala +6 more

ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells

Cancer Cell(2023)10.1016/j.ccell.2023.11.004

N/A

0DataRank · unranked

51 citations

Wei‐Tien Tai, Andrea Aroldi, Carmen Mecca, Elisa Landoni, Manuel Nüesch +16 more

ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells

UNC Libraries(2025)10.17615/thhw-qy46

N/A

0DataRank · unranked

0 citations

Manuel Nüesch, Elisa Landoni, Tongqing Li, Luca Molinaro, Andrea Aroldi +16 more